Assessment of cardiovascular performance using ultrasound methods and devices that interrogate interstitial fluid

• US 6,358,208 B1
• Filed: 11/21/1998
• Issued: 03/19/2002
• Est. Priority Date: 11/21/1998
• Status: Expired due to Fees

• Current Assignee: John D. Mendlein, Philipp Lang
• Original Assignee: John D. Mendlein, Philipp Lang
• Inventors: Lang, Philipp, Mendlein, John D.
• Primary Examiner(s): Lateef, Marvin M.
• Assistant Examiner(s): PATEL, MAULIN M
• Application Number:
  US09/196,507
• Time in Patent Office: 1,214 Days
• Field of Search: 600/437, 600/443, 600/444, 600/438, 600/449, 600/447
• US Class Current: 600/438
• CPC Class Codes: A61B 5/412 Detecting or monitoring sepsis
• CPC Class Codes: A61B 5/415 the glands, e.g. tonsils, adenoids or thymus
• CPC Class Codes: A61B 5/4869 Determining body composition
• CPC Class Codes: A61B 8/06 Measuring blood flow measuring volume flow in general G01F, e.g. G01F1/66, G01F1/72; measuring speed of fluids in general G01P5/00
• CPC Class Codes: A61B 8/0858 involving measuring tissue layers, e.g. skin, interfaces
• CPC Class Codes: A61B 8/4236 characterised by adhesive patches
• CPC Class Codes: A61B 8/543 involving acquisition triggered by a physiological signal

Abstract

The present invention provides for methods and devices for monitoring cardiovascular performance. The invention also includes methods of measuring capillary related interstitial fluid, as well as cardiac and vascular function. Specific devices, particularly probes, are provided for such methods.

Claims

1. A method of monitoring cardiovascular performance in a subject, comprising:

a) positioning an ultrasound probe on an epidermal surface of a first appendage region of a subject in need of cardiovascular performance assessment and said subject is optionally suspected of comprised or challenged cardiac, arterial, or venous function,

b) applying at least one ultrasound pulse to a subcutaneous layer of said first appendage region,

c) recording a least one ultrasound signal with said ultrasound probe from said first appendage region, and

d) detecting an interstitial fluid layer in said subcutaneous layer of said first appendage region from said at least one ultrasound signal; and

wherein detecting said interstitial fluid layer is an assessment of cardiovascular function.

2. The method of claim 1, wherein said subject is a human.

3. The method of claim 2, wherein said first appendage region is a tibia region.

4. The method of claim 3, wherein said detecting of said interstitial fluid layer extends from an inner surface of skin to either a bone, muscle or fat surface in said tibia region.

5. The method of claim 4, wherein said recording does not determine the degree of skin echogenicity.

6. The method of claim 5, further comprising calculating a distance from said inner surface to said bone or fat surface of said tibia region.

7. The method of claim 6, wherein said distance is calculated by determining the shortest reflective distance.

8. The method of claim 6, wherein said human has diabetes, compromised renal function or compromised cardiac function.

9. The method of claim 8, further comprising:

a) administering a diuretic agent, a cardiac agent or a diabetic agent,

b) positioning an ultrasound probe on an appendage region of a subject in need of cardiovascular assessment after said administration, and

c) recording ultrasound signals with said ultrasound probe from said appendage region;

d) wherein said ultrasound signals can be used to measure a capillary related edema layer in said appendage region after said administration.

10. The method of claim 5, wherein said ultrasound probe is an autonomous, hand-held ultrasound system capable of self-measurement.

11. A method of assessing vascular performance, comprising:

a) reducing or increasing blood flow or pressure to a tissue in a subject,

b) monitoring a capillary related interstitial layer thickness of said tissue with an ultrasound probe after or concurrent with said step (a),

c) increasing said blood flow to said tissue after said reducing in step (a) and said monitoring in step (b) or decreasing said blood flow to said tissue after said increasing in step (a) and said monitoring in step (b), and

d) monitoring said capillary related interstitial layer thickness of said tissue with an ultrasound probe, after or concurrent with said step (c),

wherein said reduction in blood flow controllably reduces blood flow to said tissue for a clinically relevant period of time in step (a) and said increase in blood flow controllably increases blood flow to said tissue for a clinically relevant period of time in step (c), or

wherein said increase in blood flow controllably increases blood flow to said tissue for a clinically relevant period of time in step (a) and said reduction in blood flow controllably reduces blood flow to said tissue for a clinically relevant period of time in step (c).

12. A method for non-invasively estimating dynamic cardiac performance in a human, comprising:

a) monitoring interstitial fluid content with an ultrasound probe positioned on the skin of a human in need of cardiac performance evaluation and in an anatomical region suitable for monitoring changes in interstitial fluid content during a clinically relevant time period, and

b) comparing said capillary related interstitial fluid content monitored in step (a) with a standard value for capillary related interstitial fluid content or with a measurement of capillary related interstitial fluid content in said human.

13. The method of claim 12, wherein said comparing qualitatively compares interstitial fluid content to a predetermined standard value for interstitial fluid content, wherein said comparison provides a diagnostic measure of cardiac performance.

14. The method of claim 12, wherein said human is suspected of having a medical condition that increases interstitial fluid content.

15. The method of claim 14, wherein monitoring occurs before and after elevating legs of said human.

16. A system for monitoring cardiovascular performance, comprising a heart electrical signal detection device and an ultrasound interstitial layer detection device for monitoring cardiovascular performance.

17. The system of claim 16, wherein said ultrasound interstitial layer detection device comprises a predetermined set of probes for monitoring interstitial layers a plurality of anatomical locations.

18. The system of claim 17, wherein said ultrasound interstitial layer detection device produces an image comprising an anatomical feature selected from the group of bone, skin, interstitial layer and muscle.

19. The system of claim 16, wherein said at least one ultrasound signal or data resulting from an ultrasound signal is compared with at least one electrical signal from said heart electrical signal detection device or data resulting from said heart electrical signal detection device.

20. The system of claim 19, wherein said heart electrical signal detection device is an EKG device and said EKG device can be optionally integrated into said ultrasound interstitial layer detection device.